The differential plasma proteome of obese and overweight individuals undergoing a nutritional weight loss and maintenance intervention

The nutritional intervention program “DiOGenes” focuses on how obesity can be prevented and treated from a dietary perspective. We generated differential plasma proteome profiles in the DiOGenes cohort to identify proteins associated with weight loss and maintenance and explore their relation to body mass index, fat mass, insulin resistance, and sensitivity.

[1]  Matthias Mann,et al.  Proteomics reveals the effects of sustained weight loss on the human plasma proteome , 2016, Molecular systems biology.

[2]  Loïc Dayon,et al.  Proteomic Biomarker Discovery in 1000 Human Plasma Samples with Mass Spectrometry. , 2016, Journal of proteome research.

[3]  D. Torrents,et al.  Surgery-Induced Weight Loss Is Associated With the Downregulation of Genes Targeted by MicroRNAs in Adipose Tissue. , 2015, The Journal of clinical endocrinology and metabolism.

[4]  T. Wakefield,et al.  The role of galectin-3 and galectin-3-binding protein in venous thrombosis. , 2015, Blood.

[5]  Seok-Jun Kim,et al.  Galectin-3 activates PPARγ and supports white adipose tissue formation and high-fat diet-induced obesity. , 2015, Endocrinology.

[6]  P. Guest,et al.  Proteomic Enrichment Analysis of Psychotic and Affective Disorders Reveals Common Signatures in Presynaptic Glutamatergic Signaling and Energy Metabolism , 2015, The international journal of neuropsychopharmacology.

[7]  Alan D. Lopez,et al.  Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2014, The Lancet.

[8]  M. Kussmann,et al.  Comprehensive and Scalable Highly Automated MS-Based Proteomic Workflow for Clinical Biomarker Discovery in Human Plasma. , 2014, Journal of proteome research.

[9]  Ming Yao,et al.  SWATH™- and iTRAQ-based quantitative proteomic analyses reveal an overexpression and biological relevance of CD109 in advanced NSCLC. , 2014, Journal of proteomics.

[10]  M. Banach,et al.  Obesity indices and inflammatory markers in obese non-diabetic normo- and hypertensive patients: a comparative pilot study , 2014, Lipids in Health and Disease.

[11]  Andrew R. Jones,et al.  ProteomeXchange provides globally co-ordinated proteomics data submission and dissemination , 2014, Nature Biotechnology.

[12]  Ruedi Aebersold,et al.  Automated selected reaction monitoring data analysis workflow for large-scale targeted proteomic studies , 2013, Nature Protocols.

[13]  J. Norris,et al.  Influence of Weight Loss, Body Composition, and Lifestyle Behaviors on Plasma Adipokines: A Randomized Weight Loss Trial in Older Men and Women with Symptomatic Knee Osteoarthritis , 2012, Journal of obesity.

[14]  C. H. Leung,et al.  PRAP1 is a novel executor of p53-dependent mechanisms in cell survival after DNA damage , 2012, Cell Death and Disease.

[15]  J. Moreno-Navarrete,et al.  Serum and urinary concentrations of calprotectin as markers of insulin resistance and type 2 diabetes. , 2012, European journal of endocrinology.

[16]  G. Hunter,et al.  Intra‐Abdominal Adipose Tissue Is Independently Associated With Sex‐Hormone Binding Globulin in Premenopausal Women , 2012, Obesity.

[17]  A. Astrup,et al.  Effects of Weight Loss and Long-Term Weight Maintenance With Diets Varying in Protein and Glycemic Index on Cardiovascular Risk Factors: The Diet, Obesity, and Genes (DiOGenes) Study A Randomized, Controlled Trial , 2011, Circulation.

[18]  J. Fernández-Real,et al.  Increased Levels of Calprotectin in Obesity Are Related to Macrophage Content: Impact on Inflammation and Effect of Weight Loss , 2011, Molecular medicine.

[19]  A. Astrup,et al.  Diets with high or low protein content and glycemic index for weight-loss maintenance. , 2010, The New England journal of medicine.

[20]  C. Heng,et al.  Association between serum amyloid A and obesity: a meta-analysis and systematic review , 2010, Inflammation Research.

[21]  T. Larsen,et al.  The Diet, Obesity and Genes (Diogenes) Dietary Study in eight European countries – a comprehensive design for long‐term intervention , 2010, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[22]  B. Pedersen,et al.  Calprotectin — A Novel Marker of Obesity , 2009, PloS one.

[23]  R. Gomis,et al.  Proteomics in obesity research , 2009, Proteomics. Clinical applications.

[24]  E. Ravussin,et al.  Energy metabolism, fuel selection and body weight regulation , 2008, International Journal of Obesity.

[25]  G. Ioannou,et al.  Is Obesity Associated With Anemia of Chronic Disease? A Population‐based Study , 2008, Obesity.

[26]  V. Paradis,et al.  Serum proteomic profiling of obese patients: correlation with liver pathology and evolution after bariatric surgery , 2008, Gut.

[27]  D. Laaksonen,et al.  Serum concentrations and expressions of serum amyloid A and leptin in adipose tissue are interrelated: the Genobin Study. , 2008, European journal of endocrinology.

[28]  Z. Kováčová,et al.  An increase in plasma adiponectin multimeric complexes follows hypocaloric diet-induced weight loss in obese and overweight pre-menopausal women. , 2007, Clinical science.

[29]  A. Dulloo,et al.  Suppressed thermogenesis as a cause for resistance to slimming and obesity rebound: adaptation or illusion? , 2007, International Journal of Obesity.

[30]  J. Levine,et al.  Galectin‐3 Stimulates Preadipocyte Proliferation and Is Up‐regulated in Growing Adipose Tissue , 2007, Obesity.

[31]  Da-Wei Gong,et al.  Acute-Phase Serum Amyloid A: An Inflammatory Adipokine and Potential Link between Obesity and Its Metabolic Complications , 2006, PLoS medicine.

[32]  T. Reinehr,et al.  Adiponectin before and after weight loss in obese children. , 2004, The Journal of clinical endocrinology and metabolism.

[33]  P. Rouleau,et al.  Proinflammatory Activities of S100: Proteins S100A8, S100A9, and S100A8/A9 Induce Neutrophil Chemotaxis and Adhesion 1 , 2003, The Journal of Immunology.

[34]  M. Visser,et al.  Elevated C-reactive protein levels in overweight and obese adults. , 1999, JAMA.

[35]  W. Ricart,et al.  Plasma total and glycosylated corticosteroid-binding globulin levels are associated with insulin secretion. , 1999, The Journal of clinical endocrinology and metabolism.

[36]  Y. Song,et al.  Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone , 1997, International Journal of Obesity.

[37]  M. Wabitsch,et al.  Insulin-like growth factors and their binding proteins before and after weight loss and their associations with hormonal and metabolic parameters in obese adolescent girls. , 1996, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[38]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[39]  Robert Tibshirani,et al.  Bootstrap Methods for Standard Errors, Confidence Intervals, and Other Measures of Statistical Accuracy , 1986 .

[40]  G. M. Rao,et al.  Effect of obesity on erythrocyte count and hemoglobin levels in Libyan diabetic patients. , 1986, Clinical physiology and biochemistry.

[41]  J. Mayer,et al.  Hypoferraemia in obese adolescents. , 1962, Lancet.